Business
MedMira Presents at "Behavioural Surveillance Surveys Among Injecting Drug Users and Sex Workers" Workshop in Romania
MedMira to Provide Multiplo Triple Tests as Screening Tool for Surveys HALIFAX, April 22 /CNW/ - ...
About this update from Medmira Inc.
[{"type":"text","content":"\n\n\n\nMedMira to Provide Multiplo Triple Tests as Screening Tool for Surveys\n\n\nHALIFAX, April 22 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR,\nNASDAQ: MMIRF), a global market leader in premium rapid diagnostic solutions,\nannounced today that company president & CEO, Hermes Chan, delivered a\npresentation on MedMira's HIV, Hepatitis B and C rapid test, Multiplo(TM)\nHBV/HIV/HCV at the Behavioural Surveillance Surveys (BSS) Among Injecting Drug\nUsers and Sex Workers workshop taking place in Bucharest, Romania. The\nworkshop was organized by the United Nations Office on Drugs and Crime Romania\n(UNODC).\n\n\n"We are pleased to have the opportunity to present our Multiplo test to\nthe experts gathered for this important workshop. The awareness and interest\nin Multiplo continues to increase in Eastern Europe and participation in\nprojects such as these surveillance surveys helps MedMira demonstrate the\nunequalled benefits of Multiplo to key healthcare decision makers in Romania\nand other countries in the region," said Hermes Chan, President & CEO, MedMira\nInc. "MedMira is committed to supporting prevention and control programs such\nas this and we look forward to working together on future public health\ninitiatives in other parts of the world where our Multiplo test can be of\ngreatest value."\n\n\nMedMira's Multiplo rapid tests will be used as the screening test for\ninjecting drug users and sex workers, an important focus of the BSS starting\nat the end of May this year. Multiplo is the only commercially available rapid\ntest in the world able to detect both HIV and Hepatitis C and B from a single\nspecimen in less than three minutes. The quality and versatility of Multiplo\nmake it ideal for use in programs like the BSS where patient testing will take\nplace in a variety of settings, everywhere from healthcare facilities to\nmobile testing clinics.\n\n\nAbout MedMira\n\n\nMedMira is a leading developer and manufacturer of flow-through rapid\ndiagnostics. The company's tests provide hospitals, labs, clinics and\nindividuals around the world with reliable, rapid diagnosis for diseases such\nas HIV and hepatitis C in just three minutes. The company's tests are sold\nunder the Reveal(R), MiraWell(R), MiraCare(TM) and Multiplo(TM) brands in\nglobal markets. MedMira's rapid HIV t...